MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Where Workforce Strategy Meets Facility Design
Designing healthcare facilities with the same rigor applied to clinical programming creates environments where clinicians want to stay.
OCAD Student Research Inspires Dementia Friendly Shower Redesign at UHN Hospital
The space responds to a common challenge in care environments, where showering can be disorienting and stressful due to unfamiliar surroundings, noise and limited privacy.
Atrium Health Navicent Ensnared in Oracle Health Data Breach
Currently, this incident did not involve access to credit card information or bank account information.
Two Steps to Controlling the Hot Zone
Strategy for disrupting dry-surface biofilm begins with a simple premise: You cannot disinfect what you cannot reach.
RiverSpring Living Breaks Ground on River's Edge Senior Living Community
Occupancy is expected in December 2028.